Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer
Colony-stimulating factor-1 receptor (CSF-1R) signaling promotes an immune suppressive microenvironment enriched in M2 macrophages. Given that CSF-1R inhibitors are under investigation in clinical trials, including in breast cancer, CSF-1R expression and association with immune biomarkers could iden...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/abeea43bae854238ba522f7fc6b26fb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:abeea43bae854238ba522f7fc6b26fb2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:abeea43bae854238ba522f7fc6b26fb22021-11-25T17:03:47ZPrognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer10.3390/cancers132257692072-6694https://doaj.org/article/abeea43bae854238ba522f7fc6b26fb22021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5769https://doaj.org/toc/2072-6694Colony-stimulating factor-1 receptor (CSF-1R) signaling promotes an immune suppressive microenvironment enriched in M2 macrophages. Given that CSF-1R inhibitors are under investigation in clinical trials, including in breast cancer, CSF-1R expression and association with immune biomarkers could identify patients who derive greater benefit from combination with immunotherapies. TIMER2.0 and bc-GenExMiner v4.7 were used to assess the correlation of <i>CSF1R</i> mRNA with immune infiltrates and prognosis. Following a prespecified training–validation approach, an optimized immunohistochemistry assay was applied to assess CSF-1R on carcinoma cells and macrophages on breast cancer tissue microarray series representing 2384 patients, coupled to comprehensive clinicopathological, biomarker, and outcome data. Significant positive correlations were observed between <i>CSF1R</i> mRNA and immune infiltrates. High carcinoma CSF-1R correlated with grade 3 tumors >2 cm, hormone receptor negativity, high Ki67, immune checkpoint biomarkers, and macrophages expressing CSF-1R and CD163. High carcinoma CSF-1R was significantly associated with poor survival in univariate and multivariate analyses. Adverse prognostic associations were retained in ER+ cases regardless of the presence of CD8+ T cells. CSF-1R+ macrophages were not prognostic. High carcinoma CSF-1R is associated with aggressive breast cancer biology and poor prognosis, particularly in ER+ cases, and identifies patients in whom biomarker-directed CSF-1R therapies may yield superior therapeutic responses.Nazia RiazSamantha BuruguAngela S. ChengSamuel C. Y. LeungDongxia GaoTorsten O. NielsenMDPI AGarticlecolony-stimulating factor-1 receptorimmunohistochemistryprognosisestrogen receptor-positive breast cancerinvasive breast cancerimmune check pointsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5769, p 5769 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
colony-stimulating factor-1 receptor immunohistochemistry prognosis estrogen receptor-positive breast cancer invasive breast cancer immune check points Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
colony-stimulating factor-1 receptor immunohistochemistry prognosis estrogen receptor-positive breast cancer invasive breast cancer immune check points Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Nazia Riaz Samantha Burugu Angela S. Cheng Samuel C. Y. Leung Dongxia Gao Torsten O. Nielsen Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer |
description |
Colony-stimulating factor-1 receptor (CSF-1R) signaling promotes an immune suppressive microenvironment enriched in M2 macrophages. Given that CSF-1R inhibitors are under investigation in clinical trials, including in breast cancer, CSF-1R expression and association with immune biomarkers could identify patients who derive greater benefit from combination with immunotherapies. TIMER2.0 and bc-GenExMiner v4.7 were used to assess the correlation of <i>CSF1R</i> mRNA with immune infiltrates and prognosis. Following a prespecified training–validation approach, an optimized immunohistochemistry assay was applied to assess CSF-1R on carcinoma cells and macrophages on breast cancer tissue microarray series representing 2384 patients, coupled to comprehensive clinicopathological, biomarker, and outcome data. Significant positive correlations were observed between <i>CSF1R</i> mRNA and immune infiltrates. High carcinoma CSF-1R correlated with grade 3 tumors >2 cm, hormone receptor negativity, high Ki67, immune checkpoint biomarkers, and macrophages expressing CSF-1R and CD163. High carcinoma CSF-1R was significantly associated with poor survival in univariate and multivariate analyses. Adverse prognostic associations were retained in ER+ cases regardless of the presence of CD8+ T cells. CSF-1R+ macrophages were not prognostic. High carcinoma CSF-1R is associated with aggressive breast cancer biology and poor prognosis, particularly in ER+ cases, and identifies patients in whom biomarker-directed CSF-1R therapies may yield superior therapeutic responses. |
format |
article |
author |
Nazia Riaz Samantha Burugu Angela S. Cheng Samuel C. Y. Leung Dongxia Gao Torsten O. Nielsen |
author_facet |
Nazia Riaz Samantha Burugu Angela S. Cheng Samuel C. Y. Leung Dongxia Gao Torsten O. Nielsen |
author_sort |
Nazia Riaz |
title |
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer |
title_short |
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer |
title_full |
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer |
title_fullStr |
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer |
title_full_unstemmed |
Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer |
title_sort |
prognostic significance of csf-1r expression in early invasive breast cancer |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/abeea43bae854238ba522f7fc6b26fb2 |
work_keys_str_mv |
AT naziariaz prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer AT samanthaburugu prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer AT angelascheng prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer AT samuelcyleung prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer AT dongxiagao prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer AT torstenonielsen prognosticsignificanceofcsf1rexpressioninearlyinvasivebreastcancer |
_version_ |
1718412795407499264 |